Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIPA like domain containing 1 | 0.760 | 0.346 | 2.5E-10 |
|
disease | 0.100 | None | 1.000 | 6 | 8 | 1995 | 2019 | ||||||||
|
PHD finger protein 3 | 0.760 | 0.192 | 0.99 |
|
disease | 0.100 | None | 1.000 | 2 | 13 | 2018 | 2019 | ||||||||
|
zinc finger DHHC-type containing 24 | 0.722 | 0.462 | 4.2E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2002 | 2019 | ||||||||
|
phytanoyl-CoA 2-hydroxylase | 0.659 | 0.577 | 2.4E-06 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 1997 | 2004 | ||||||||
|
Bardet-Biedl syndrome 10 | 0.644 | 0.538 | 1.7E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2006 | 2006 | ||||||||
|
RCC1 and BTB domain containing protein 1 | 0.572 | 0.692 | 1.6E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2016 | 2016 | ||||||||
|
CLRN1 antisense RNA 1 | 0.821 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2002 | 2002 | |||||||||
|
cyclic nucleotide gated channel subunit beta 3 | 0.633 | 0.192 | 7.8E-19 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
CDH23 antisense RNA 1 | 0.839 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
NADH:ubiquinone oxidoreductase core subunit V1 | 0.617 | 0.538 | 6.4E-11 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase subunit S4 | 0.587 | 0.808 | 3.1E-04 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase core subunit S8 | 0.636 | 0.538 | 0.17 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase core subunit V2 | 0.610 | 0.500 | 5.6E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase core subunit S3 | 0.581 | 0.769 | 5.8E-04 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ATPase Na+/K+ transporting subunit alpha 2 | 0.597 | 0.615 | 1.8E-04 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
translational activator of cytochrome c oxidase I | 0.647 | 0.577 | 1.5E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B | 0.527 | 0.769 | 2.4E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
peroxiredoxin 1 | 0.485 | 0.846 | 7.7E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
acyl-CoA oxidase 1 | 0.610 | 0.731 | 6.2E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
nephrocystin 1 | 0.572 | 0.731 | 1.2E-17 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
WD repeat containing planar cell polarity effector | 0.576 | 0.769 | 1.1E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase subunit A13 | 0.556 | 0.692 | 3.8E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase core subunit S2 | 0.601 | 0.654 | 1.4E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase core subunit S1 | 0.595 | 0.692 | 6.6E-11 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
MTND2 | 0.601 | 0.615 |
|
disease | 0.100 | None | 0 | 0 |